CPG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

Details for Australian Patent Application No. 2007330410 (hide)

Owner Coley Pharmaceutical GmbH

Inventors Uhlmann, Eugen; Jurk, Marion; Debelak, Harald

Agent Spruson & Ferguson

Pub. Number AU-B-2007330410

PCT Pub. Number WO2008/068638

Priority 60/847,811 27.09.06 US

Filing date 27 September 2007

Wipo publication date 12 June 2008

Acceptance publication date 26 July 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 37/04 Drugs for immunological or allergic disorders

C12N 15/117 Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/068638 Priority application(s): WO2008/068638

3 May 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Coley Pharmaceutical GmbH, Application No. 2007330410, under INID (22) correct the date to 27.09.2007

26 July 2012 Application Accepted

  Published as AU-B-2007330410

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007330415-Knockdown storage vessel

2007330409-OB-fold used as scaffold for engineering new specific binders